A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

NCT02052726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile

Interventions

BIOLOGICAL: C. difficile vaccine with adjuvant
BIOLOGICAL: Placebo
BIOLOGICAL: C. difficile vaccine with adjuvant
BIOLOGICAL: placebo

Sponsor

Pfizer